![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Leukemia |
Free Subscription
2 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for
response to induction chemotherapy.
Am J Hematol. 2022 Jun 15. doi: 10.1002/ajh.26630.
PubMed
Abstract available
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of
allogeneic stem cell transplantation on survival.
Am J Hematol. 2022;97:E232-E235.
PubMed
The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia.
Ann Hematol. 2022 Jun 15. pii: 10.1007/s00277-022-04874.
PubMed
KIR3DL2 contributes to the typing of acute-type adult T-cell leukemia and is a
potential therapeutic target.
Blood. 2022 Jun 10. pii: 485527. doi: 10.1182/blood.2022016765.
PubMed
Abstract available
Functional mapping of PHF6 complexes in chromatin remodeling, replication
dynamics, and DNA repair.
Blood. 2022;139:3418-3429.
PubMed
Abstract available
Follow-up of patients with R/R FLT3-mutation-positive AML treated with
gilteritinib in the phase 3 ADMIRAL trial.
Blood. 2022;139:3366-3375.
PubMed
Abstract available
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease
prophylaxis after allogeneic stem cell transplantation for acute myeloid
leukemia.
Bone Marrow Transplant. 2022 Jun 9. pii: 10.1038/s41409-022-01725.
PubMed
Abstract available
Clinical outcomes of second relapsed and refractory first relapsed paediatric
AML: A retrospective study within the NOPHO-DB SHIP consortium.
Br J Haematol. 2022;197:755-765.
PubMed
Abstract available
Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid
malignancies.
Br J Haematol. 2022;197:691-696.
PubMed
Abstract available
Therapy-related myeloid neoplasms with normal karyotype show distinct genomic and
clinical characteristics compared to their counterparts with abnormal karyotype.
Br J Haematol. 2022;197:736-744.
PubMed
Abstract available
Asparaginase encapsulated in erythrocytes as second-line treatment in
hypersensitive patients with acute lymphoblastic leukaemia.
Br J Haematol. 2022;197:745-754.
PubMed
Abstract available
Identification of a recurrent fusion NUP98-RARG in acute myeloid leukaemia
resembling acute promyelocytic leukaemia.
Br J Haematol. 2022;197:e73-e78.
PubMed
Treating second-relapsed/refractory first-relapsed childhood acute myeloid
leukaemia: Successful salvage rather than palliation?
Br J Haematol. 2022;197:651-652.
PubMed
Abstract available
Real-world analysis of main clinical outcomes in patients with polycythemia vera
treated with ruxolitinib or best available therapy after developing
resistance/intolerance to hydroxyurea.
Cancer. 2022;128:2441-2448.
PubMed
Abstract available
miR-146a, miR-196a2, miR-499, and miR-149 linked with susceptibility to acute
lymphoblastic leukemia: A case-control study in Tunisia.
Gene. 2022;834:146648.
PubMed
Abstract available
Design of a targeted next-generation DNA sequencing panel for pediatric T-cell
lymphoblastic lymphoma to unravel biology and optimize treatment.
Genes Chromosomes Cancer. 2022;61:459-470.
PubMed
Abstract available
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation:
Defining Targets for Intervention.
J Clin Oncol. 2022 Jun 13:JCO2200307. doi: 10.1200/JCO.22.00307.
PubMed
Abstract available
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine
Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute
Myeloid Leukemia.
J Clin Oncol. 2022 Jun 15:JCO2102823. doi: 10.1200/JCO.21.02823.
PubMed
Abstract available
The Oncology Care Model and Adherence to Oral Cancer Drugs: A
Difference-in-Differences Analysis.
J Natl Cancer Inst. 2022;114:871-877.
PubMed
Abstract available
Drug Induced Diabetes Mellitus (DIDM) in Pediatric Acute Lymphoblastic Leukemia:
Approach to diagnosis and management.
J Pediatr Hematol Oncol. 2022 Jun 7. pii: 00043426-990000000-00044.
PubMed
Abstract available
The Evaluation of Central Venous Catheter-related Complications in Pediatric
Acute Leukemia Patients: Single Center Experience.
J Pediatr Hematol Oncol. 2022 Jun 7. pii: 00043426-990000000-00042.
PubMed
Abstract available
Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA
Transcription and HBV Replication through Genetic Downregulation of Hepatocyte
Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular
DNA via Inter
J Virol. 2022 Jun 13:e0054622. doi: 10.1128/jvi.00546.
PubMed
Abstract available
Adherence to ibrutinib remains an unmet clinical need in chronic lymphocytic
leukemia.
Leuk Lymphoma. 2022 Jun 15:1-3. doi: 10.1080/10428194.2022.2087072.
PubMed
Single-cell RNA sequencing to explore composition of peripheral blood NK cells in
patients with chronic myeloid leukemia in treatment-free remission.
Leuk Lymphoma. 2022 Jun 11:1-12. doi: 10.1080/10428194.2022.2086243.
PubMed
Abstract available
Whole-genome sequencing as an alternative to analyze copy number abnormalities in
acute myeloid leukemia and myelodysplastic syndrome.
Leuk Lymphoma. 2022 Jun 11:1-10. doi: 10.1080/10428194.2022.2080821.
PubMed
Abstract available
Poor clinical outcome of elderly patients with primary plasma cell leukemia
treated with novel agents: real-world experience.
Leuk Lymphoma. 2022 Jun 10:1-5. doi: 10.1080/10428194.2022.2086250.
PubMed
PTPN11 mutations in adult acute myeloid leukaemia: Prevalence and clinical
implications in the context of NPM1 mutation.
Leuk Res. 2022;118:106859.
PubMed
Abstract available
Resurgence of myeloproliferative neoplasm in patients in remission from blast
transformation after treatment with hypomethylating agents.
Leuk Res. 2022;118:106871.
PubMed
Abstract available
NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN
frequently harbours secondary-type mutations and confers inferior outcome
compared to AML with mutated NPM1.
Leuk Res. 2022;118:106869.
PubMed
Abstract available
Major clinical response in a patient with leukemia cutis treated with the
bromodomain inhibitor PLX51107 and azacitidine.
Leuk Res. 2022;119:106884.
PubMed
Remodeling of the m(6)A RNA landscape in the conversion of acute lymphoblastic
leukemia cells to macrophages.
Leukemia. 2022 Jun 9. pii: 10.1038/s41375-022-01621.
PubMed
Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis
of chronic myelomonocytic leukemia.
Leukemia. 2022 Jun 14. pii: 10.1038/s41375-022-01605.
PubMed
Abstract available
Evaluating immune response and metabolic related biomarkers pre-allogenic
hematopoietic stem cell transplant in acute myeloid leukemia.
PLoS One. 2022;17:e0268963.
PubMed
Abstract available
The incidence and mortality of childhood acute lymphoblastic leukemia in
Indonesia: A systematic review and meta-analysis.
PLoS One. 2022;17:e0269706.
PubMed
Abstract available
Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity
against NPM1 mutated acute myeloid leukemia.
Proc Natl Acad Sci U S A. 2022;119:e2122379119.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by